Atypical Fibroxanthoma of the Bulbar Conjunctiva.
Data(s) |
01/12/2015
|
---|---|
Formato |
1620 - 1622 |
Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/26509771 Cornea, 2015, 34 (12), pp. 1620 - 1622 http://hdl.handle.net/10161/11095 1536-4798 |
Relação |
Cornea 10.1097/ICO.0000000000000658 |
Palavras-Chave | #Adult #Alkylating Agents #Combined Modality Therapy #Conjunctival Diseases #Cryotherapy #Female #Humans #Limbus Corneae #Mitomycin #Sclera #Tenon Capsule #Xanthomatosis |
Tipo |
Journal Article |
Cobertura |
United States |
Resumo |
PURPOSE: To report a rare case of atypical fibroxanthoma (AFX) of the bulbar conjunctiva, and to compare it with previously published cases of conjunctival AFX. METHODS: A 37-year-old woman developed a growth on the bulbar conjunctiva of her left eye that increased in size and redness over 4 months and was associated with blurry vision in the left eye, occasional diplopia, irritation of the eye, and increasing tearing. The mass was surgically excised. RESULTS: Slit-lamp examination disclosed a highly vascularized conjunctival lesion with intact lustrous epithelium and a raised nodular edge encroaching on the nasal corneal limbus of the left eye. Pathological examination and immunohistochemistry were diagnostic of AFX. CONCLUSIONS: AFX of the conjunctiva is rare, with this being only the fifth example of this neoplasm reported at this site. Complete surgical excision is the most appropriate treatment option. |
Idioma(s) |
ENG |